AgomAb Therapeutics N.V. American Shares
AGMB | NASDAQ
$7.49
-$0.46 (-5.79%)
At close: Oct 30, 2026, 4:00 PM ET
$7.49
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a |
Operating Income | -59.28M | -48.02M | -31.19M | -22.63M |
Interest Income | 1.61M | 1.22M | 245K | 71K |
Pretax Income | -62.55M | -46.26M | -12.01M | -10.81M |
Net Income | -62.55M | -46.27M | -11.39M | -8.14M |
Selling & General & Admin | 12.57M | 9.82M | 6M | 4.49M |
Research & Development | 48.88M | 39.31M | 26.31M | 19.42M |
Other Expenses | -2.17M | -1.11M | -1.12M | -1.28M |
Operating Expenses | 59.28M | 48.02M | 31.19M | 22.63M |
Interest Expense | 60K | 67K | 31K | 45K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 59.28M | 48.02M | 31.19M | 22.63M |
Income Tax Expense | n/a | 4K | -619K | -2.66M |
Shares Outstanding (Basic) | 48.74M | 36.24M | 36.24M | 36.24M |
Shares Outstanding (Diluted) | 48.74M | 36.24M | 36.24M | 36.24M |
EPS (Basic) | -1.28 | -1.26 | -0.31 | -0.22 |
EPS (Diluted) | -1.28 | -1.26 | -0.31 | -0.22 |
EBITDA | -62.27M | -45.89M | -11.88M | -10.74M |
EBIT | -62.49M | -46.2M | -11.98M | -10.76M |
Depreciation & Amortization | 219K | 311K | 99K | 23K |
Add to Watchlist
Select watchlists to add or remove AGMB